openPR Logo
Press release

Yeast Infection Market 2018 Leading Player | Merck & Co, Astellas, Abbott, Novartis AG, Sanofi, AstraZeneca and More

03-26-2018 11:16 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Market Research Future

Yeast Infection Market 2018 Leading Player | Merck & Co,

The Global Yeast Infection Market is expected to grow at a CAGR of 5.2% during the forecasted period 2018-2023.

The Global Yeast Infection Market is growing with the rapid pace; mainly due to the increasing prevalence of yeast infection, and rising awareness about the diagnosis and treatment of yeast infection. According to a recent study report published by the Market Research Future, the global yeast infection market is booming, and expected to gain prominence over the forecast period growing rapidly .The market is expected to demonstrate a spectacular growth by 2023, surpassing its previous growth records in terms of value with a striking CAGR during the anticipated period (2017 – 2023).

Get a Sample Copy of This Report @ https://www.marketresearchfuture.com/sample_request/4228 .

Yeast infection or candidiasis, a type of fungal infection, is caused by numerous types of yeast called Candida. Fungal infection can occur in both systemic and superficial parts of the body, and can affect: eye, ear, skin, mouth, and vagina and causes diseases such as fungal meningitis, ringworm and athlete's foot and are commonly found on the skin, hair, and nails. Globally, 15% of population suffers from athlete’s foot. North America is the largest market for antifungal treatment market. Nearly 1.5 million different species of fungi on the earth, however only around 300 are responsible for causing diseases and infection in human. According to the survey carried out by Cidara Therapeutics, Inc. (2015), approximately 97,000 deaths are associated annually in the U.S. with fungal infections.

Competitive Analysis:

Scynexis (US), Synmedic Laboratories (India), Merck & Co., Inc. (US), Astellas (Japan), Bayer AG (Germany), Mentis Pharma Ltd. (India), Abbott (US), Novartis AG (Switzerland), Pfizer Inc. (US), Sanofi (France), ALLERGAN (Ireland), AstraZeneca (UK) are some of the prominent players at the forefront of competition in the global yeast infection market and are profiled in MRFR Analysis.

Well established players incorporate acquisition, collaboration, partnership, expansion, and product launch in order to gain competitive advantage in this market and to maintain their market position.

Bayer AG:

Bayer AG, headquartered in Germany, focuses on research, development, production, and distribution of medical products for the prevention, diagnosis and treatment of fungal diseases.

Canespro is treatment method from Bayer AG for fungal infections occurred in nails. Canespro softens the infected part of the nails only.
Pfizer Inc.:

June, 2017: Pfizer Inc. received exclusive commercialization rights in Europe for Cresemba, which is a novel treatment for potentially life-threatening fungal infections in immunocompromised patients
August, 2016: Pfizer Inc. announced its entry into an agreement with AstraZeneca to acquire the development, and commercialization rights to its late-stage small molecule anti-infectives business
Sanofi:

November, 2014: Sanofi and its subsidiary Genzyme has announced the approval of Lemtrada by U.S. Food and Drug Administration (FDA).
Merck:

Merck develops and markets broad portfolio of 300,000 products across the globe. The company is a market leader in pharmaceutical, and biotechnological having strong presence in various parts of the world.

Get Attractive Discount on This Report @ https://www.marketresearchfuture.com/check-discount/4228 .

January, 2015: The Merck has acquire Cubist Pharmaceuticals. This acquisition will help the company to increase its revenue, and establish stronger position in hospital acute care

February, 2016: AureoGen Biosciences Inc., signed an agreement with Merck for the application of AureoGen’s proprietary chemistry and compounds in the development of medicines for infectious disease, which include systemic fungal infections.
…Continued

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:
Market Research Future
+1 646 845 9312
Email: sales@marketresearchfuture.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Yeast Infection Market 2018 Leading Player | Merck & Co, Astellas, Abbott, Novartis AG, Sanofi, AstraZeneca and More here

News-ID: 991897 • Views:

More Releases from Market Research Future

Denim Market Size By 2035 with 5.25 USD Billion in 2025 to 132.4 USD Billion, Due To Due to increasing popularity of Denim jeans, Denim jackets, and other denim apparel.
Denim Market Size By 2035 with 5.25 USD Billion in 2025 to 132.4 USD Billion, Du …
Denim Market Size Grow at a 75.25 USD Billion in 2025 to 132.4 USD Billion by 2035, CAGR of 5.81% By 2025 - 2035 Global Denim Market is entering a new phase of transformation as consumer demand, fashion cycles, and sustainable innovation continue to reshape the industry. Denim, once considered a classic wardrobe staple, has evolved into a versatile, fashion-driven category supported by innovations in fabric technology, eco-friendly production, and shifting
Humanoid Robots Market Size to Reach USD 13.8 Billion by 2032, Growing at 50.2% CAGR from 2024
Humanoid Robots Market Size to Reach USD 13.8 Billion by 2032, Growing at 50.2% …
The global Humanoid Robots Market is projected to reach USD 13.8 Billion by 2032, growing at a robust CAGR of 50.2% during the forecast period from 2024 to 2032. Driven by advancements in artificial intelligence, machine learning, and machine vision, humanoid robots-designed with human-like characteristics-are witnessing widespread adoption across healthcare, education, space exploration, and service industries. These robots are enhancing operational efficiency, performing complex tasks, and improving customer engagement across multiple
Vertical Farming Market Expansion: USD 9.023 Billion in 2025 Growing to USD 58.83 Billion by 2035
Vertical Farming Market Expansion: USD 9.023 Billion in 2025 Growing to USD 58.8 …
The Vertical Farming Market was estimated at USD 7.48 Billion in 2024 and is projected to grow from USD 9.023 Billion in 2025 to USD 58.83 Billion by 2035, exhibiting a robust CAGR of 20.62% during the forecast period from 2025 to 2035. Driven by increasing demand for sustainable agriculture, urbanization, and technological advancements in controlled-environment farming, vertical farming solutions are seeing widespread adoption across commercial, industrial, and urban agriculture sectors. Key
Robotics Market Trends and Forecast: USD 74,120.70 Million in 2024 Expected to Hit USD 476,019.67 Million by 2035
Robotics Market Trends and Forecast: USD 74,120.70 Million in 2024 Expected to H …
The Robotics Market was valued at USD 74,120.70 Million in 2024 and is projected to reach USD 476,019.67 Million by 2035, growing at a robust CAGR of 18.4% during the forecast period from 2024 to 2035. Driven by advancements in medical robots, growing industrial robotics adoption, and the development of AI technologies, robotics solutions are witnessing widespread adoption across healthcare, manufacturing, logistics, and service sectors. Despite challenges like high initial costs

All 5 Releases


More Releases for Merck

Swine Fever Vaccine Market Detailed in New Research Report By 2032 | Merck & Co. …
🚀 𝐒𝐰𝐢𝐧𝐞 𝐅𝐞𝐯𝐞𝐫 𝐕𝐚𝐜𝐜𝐢𝐧𝐞 𝐌𝐚𝐫𝐤𝐞𝐭 𝐭𝐨 𝐠𝐫𝐨𝐰 𝐚𝐭 𝐚 𝐂𝐀𝐆𝐑 𝐨𝐟 𝟓.𝟗% (𝟐𝟎𝟐𝟓 - 𝟐𝟎𝟑𝟐) The Swine Fever Vaccine Market Report is the result of extensive research and analysis conducted by our team of experienced market researchers through - » 70% efforts of Primary Research » 15% efforts of Secondary Research » 15% efforts from the subscription to Paid database providing industry overview, macro and micro economics factors, and financials of private limited companies 📈
Women's Health Market Industry Growth Report to 2031 Merck KGaA, Merck & Co, Fer …
[New York, December 2024] Women's Health encompasses a broad spectrum of medical and wellness services tailored to address the unique health needs of women across all life stages. This crucial sub-market of healthcare highlights the necessity for specialized treatments, preventive care, and holistic wellness approaches that resonate with today's female patients. Women's Health isn't just a niche sector; it represents a burgeoning field within healthcare, mirrored by an increasing global
Laboratory Syringe Market Size, Growing Demand to 2036 GESERCO, Merck Millipore, …
A laboratory syringe is a precise instrument commonly used for the accurate measurement and transfer of liquids or gases in scientific experiments. Unlike standard medical syringes, laboratory syringes are often made of materials such as glass or high-quality plastic to withstand chemical reactions and offer greater clarity for observing contents. They come in a range of sizes, from as small as 1 mL to over 100 mL, and are often
Leuprorelin Acetate Market Analysis By Top Keyplayers - Merck, Takeda, MediGene, …
The "Leuprorelin Acetate Market" is expected to reach USD xx.x billion by 2031, indicating a compound annual growth rate (CAGR) of xx.x percent from 2024 to 2031. The market was valued at USD xx.x billion In 2023. Growing Demand and Growth Potential in the Global Leuprorelin Acetate Market, 2024-2031 Verified Market Research's most recent report, "Leuprorelin Acetate Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2030," provides an in-depth
Avelumab Market Analysis By Top Key Players - Merck, Pfizer, Merck
The "Avelumab Market" is expected to reach USD xx.x billion by 2031, indicating a compound annual growth rate (CAGR) of xx.x percent from 2024 to 2031. The market was valued at USD xx.x billion In 2023. Growing Demand and Growth Potential in the Global Avelumab Market, 2024-2031 Verified Market Research's most recent report, "Avelumab Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2030," provides an in-depth examination of the
Nanobodies Market to See Booming Growth 2021-2028 | Novo Nordisk A/S, Merck & Co …
𝐍𝐚𝐧𝐨𝐛𝐨𝐝𝐢𝐞𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 top level players are analyzed in report based on current and future development status, and Nanobodies market estimations from 2021 to 2028 in terms of revenue and volume. This report provides strategic recommendations consulted by the industrial experts including market share worldwide, future outlook, cost profit structure, supply, raw materials, labour cost, manufacturing expenses, latest market trends, demands, ROI. The Nanobodies market report analyse the manufacturing cost of the